MERRIMACK PHARMACEUTICALS INC Business Finance Contracts & Agreements
33 Contracts & Agreements
- Credit Agreements (1 contract)
- Exchange Agreements (3)
- Indenture Agreements (3)
- Investor Rights Agreements (2)
- Loan Agreements (8)
- Purchase Agreements (4)
- Stock Agreements (3)
- Underwriting Agreements (3)
- Waiver Agreements (1)
- Warrant Agreements (5)
- Asset Purchase Agreement, dated as of March 27, 2020, between Merrimack Pharmaceuticals, Inc. and Celator Pharmaceuticals, Inc (Filed With SEC on March 30, 2020)
- Stock Purchase Agreement, dated as of May 7, 2019, by and among the Registrant, HNKK Holdings Limited and Silver Creek Pharmaceuticals, Inc (Filed With SEC on July 17, 2019)
- Amendment No. 2 to Asset Purchase Agreement, dated as of June 28, 2019, between Merrimack Pharmaceuticals, Inc. and 14ner Oncology, Inc (Filed With SEC on July 1, 2019)
- Amendment No 1. to Asset Purchase Agreement, dated as of June 24, 2019, between Merrimack Pharmaceuticals, Inc. and 14ner Oncology, Inc (Filed With SEC on June 24, 2019)
- Asset Purchase Agreement, dated as of May 28, 2019, by and between Merrimack Pharmaceuticals, Inc. and 14ner Oncology, Inc (Filed With SEC on May 30, 2019)
- Consent and Amendment No. 1 to Loan and Security Agreement, dated as of December 27, 2018, by and among the Registrant, the several banks and other financial institutions or... (Filed With SEC on March 6, 2019)
- Loan and Security Agreement, dated as of July 2, 2018, by and among the Registrant, certain subsidiaries of the Registrant from time to time party thereto, the several banks and... (Filed With SEC on July 3, 2018)
- Specimen certificate evidencing shares of common stock (Filed With SEC on March 12, 2018)
- Stipulation and Agreement of Settlement and Release, dated October 6, 2017, among Wells Fargo Bank, National Association, Wolverine Flagship Fund Trading Limited, 1992 MSF... (Filed With SEC on October 10, 2017)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 1, 2017)
- LOAN AND SECURITY AGREEMENT Dated as of November 8, 2016 between MERRIMACK PHARMACEUTICALS, INC. (as Borrower), and BIOPHARMA CREDIT INVESTMENTS IV SUB, LP (as Lender) LOAN AND... (Filed With SEC on March 1, 2017)
- MERRIMACK PHARMACEUTICALS, INC., as Issuer, and any Guarantorthat becomes party hereto pursuant to Section 4.10 hereof 11.5% Senior Secured Notes due 2022 INDENTURE Dated as... (Filed With SEC on December 22, 2015)
- FOURTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on February 27, 2015)
- THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 10, 2014)
- SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on June 30, 2014)
- MERRIMACK PHARMACEUTICALS, INC. AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee FIRST SUPPLEMENTAL INDENTURE Dated as of July 17, 2013 4.50% Convertible Senior Notes due... (Filed With SEC on July 18, 2013)
- MERRIMACK PHARMACEUTICALS, INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION Trustee INDENTURE Dated as of July 17, 2013 SENIOR DEBT SECURITIES (Filed With SEC on July 18, 2013)
- Amendment, Consent and Waiver (Filed With SEC on July 12, 2013)
- J.P. MORGAN SECURITIES LLC MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED MERRIMACK PHARMACEUTICALS, INC. 4.50% Convertible Senior Notes due 2020 Underwriting Agreement (Filed With SEC on July 12, 2013)
- J.P. MORGAN SECURITIES LLC MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED MERRIMACK PHARMACEUTICALS, INC. 5,000,000 Shares of Common Stock, par value $0.01 per share... (Filed With SEC on July 12, 2013)
- FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on March 20, 2013)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on November 14, 2012)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. RIGHT OF REVIEW AGREEMENT (Filed With SEC on August 14, 2012)
- J.P. MORGAN SECURITIES LLC MERRIMACK PHARMACEUTICALS, INC. [] Shares of Common Stock, par value $0.01 per share Underwriting Agreement (Filed With SEC on January 13, 2012)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. ASSIGNMENT, SUBLICENSE AND COLLABORATION AGREEMENT by... (Filed With SEC on October 26, 2011)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. LICENSE AGREEMENT Between Hermes Biosciences, Inc. And... (Filed With SEC on October 26, 2011)
- Merrimack Pharmaceuticals, Inc. 1999 Stock Option Plan (as amended) (Filed With SEC on July 8, 2011)
- Form of warrant to purchase shares of Common Stock issued by the Registrant to various parties expiring on March 10, 2016 Holder Issue date Number of shares Brookbridge... (Filed With SEC on July 8, 2011)
- Form of warrant to purchase shares of Common Stock issued by the Registrant to various parties expiring on December 10, 2015 Holder Issue date Number of shares NG White Cloud, LLC... (Filed With SEC on July 8, 2011)
- Form of warrant to purchase shares of Common Stock issued by the Registrant to General Electric Capital Corporation Issue date Number of shares 11/22/2006 797 11/22/2006 761... (Filed With SEC on July 8, 2011)
- Form of warrant to purchase shares of Common Stock issued by the Registrant to HF HoldingABI, MS Seed Capital Partners, LP and Wren Holdings LLC Holder Number of shares HF... (Filed With SEC on July 8, 2011)
- WARRANT AGREEMENT To Purchase Shares of the Series D Preferred Stock of Merrimack Pharmaceuticals, Inc. Dated as of April 6, 2005 (the Effective Date) (Filed With SEC on July 8, 2011)
- FIFTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on July 8, 2011)
